← FDA DRUG APPROVALS

FDA ANDA · ANDA085269

MECLIZINE HYDROCHLORIDE

Sponsor: ANI PHARMS

APPLICATION
ANDA085269
TYPE
ANDA
ORIGINAL APPROVAL
1976-11-11
LATEST ACTION
1998-06-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MECLIZINE HYDROCHLORIDEDiscontinued
MECLIZINE HYDROCHLORIDE 12.5MG · TABLET · ORAL

Approval history

1998-06-15Manufacturing (CMC) · Supplement 26AP
1998-06-15Manufacturing (CMC) · Supplement 27AP
1989-03-28Manufacturing (CMC) · Supplement 23AP
1988-05-09Labeling · Supplement 19AP
1987-09-14Manufacturing (CMC) · Supplement 14AP
1987-09-14Manufacturing (CMC) · Supplement 13AP
1983-08-26Manufacturing (CMC) · Supplement 11AP
1982-05-04Manufacturing (CMC) · Supplement 9AP
1982-05-04Manufacturing (CMC) · Supplement 4AP
1976-11-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →